본문 바로가기
KERD
논문KCI 등재

Dickkopf-1 is involved in BMP9-induced osteoblast differentiation of C3H10T1/2 mesenchymal stem cells

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류화학

초록

Bone morphogenetic protein 9 (BMP9) is a potent inducer of osteogenic differentiation of mesenchymal stem cells. The Wnt antagonist Dickkopf-1 (Dkk1) is involved in skeletal development and bone remodeling. Here, we investigated the role of Dkk1 in BMP9-induced osteogenic differentiation of MSCs. We found that overexpression of BMP9 induced Dkk1 expression in a dose-dependent manner, which was reduced by the P38 inhibitor SB203580 but not the ERK inhibitor PD98059. Moreover, Dkk1 dramatically decreased not only BMP9-induced alkaline phosphatase (ALP) activity but also the expression of osteocalcin (OCN) and osteopontin (OPN) and matrix mineralization of C3H10T1/2 cells. Furthermore, exogenous Dkk1 expression inhibited Wnt/β-catenin signaling induced by BMP9. Our findings indicate that Dkk1 negatively regulates BMP9-induced osteogenic differentiation through inhibition of the Wnt/β-catenin pathway and it could be used to optimize the therapeutic use of BMP9 and for bone tissue engineering.

Abstract

Bone morphogenetic protein 9 (BMP9) is a potent inducer of osteogenic differentiation of mesenchymal stem cells. The Wnt antagonist Dickkopf-1 (Dkk1) is involved in skeletal development and bone remodeling. Here, we investigated the role of Dkk1 in BMP9-induced osteogenic differentiation of MSCs. We found that overexpression of BMP9 induced Dkk1 expression in a dose-dependent manner, which was reduced by the P38 inhibitor SB203580 but not the ERK inhibitor PD98059. Moreover, Dkk1 dramatically decreased not only BMP9-induced alkaline phosphatase (ALP) activity but also the expression of osteocalcin (OCN) and osteopontin (OPN) and matrix mineralization of C3H10T1/2 cells. Furthermore, exogenous Dkk1 expression inhibited Wnt/β-catenin signaling induced by BMP9. Our findings indicate that Dkk1 negatively regulates BMP9-induced osteogenic differentiation through inhibition of the Wnt/β-catenin pathway and it could be used to optimize the therapeutic use of BMP9 and for bone tissue engineering.

참고문헌 (37)

  1. Cheng H, "Osteogenic activity of the fourteen types of human bone morphogenetic proteins(BMPs)", J Bone Joint Surg Am, 85-a, pp.1544~1552 (2003)
  2. Miyazono K, "Bone morphogenetic protein receptors, signal transduction", J Biochem, 147, pp.35~51 (2010)
  3. Lamplot JD, "BMP9 signaling in stem cell differentiation, osteogenesis", Am J Stem Cells, 2, pp.1~21 (2013)
  4. Song JJ, "Bone morphogenetic protein-9 binds to liver cells, stimulates proliferation", Endocrinology, 136, pp.4293~4297 (1995)
  5. Luu HH, "Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells", J Orthop Res, 25, pp.665~677 (2007)
  6. Luther G, "BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism, therapeutic potential", Curr Gene Ther, 11, pp.229~240 (2011)
  7. Zhang Y, "A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2", Proc Natl Acad Sci U S A, 108, pp.9863~9868 (2011)
  8. Zhao GQ, "Consequences of knocking out BMP signaling in the mouse", Genesis, 35, pp.43~56 (2003)
  9. Wang J, "The canonical Wnt pathway in early mammalian embryogenesis, stem cell maintenance", differentiation, 2004, pp.14, 533~539
  10. Clevers H, "Wnt", beta-catenin signaling in development, disease, 2006, pp.127, 469~480
  11. Glass DA 2nd, "In vivo analysis of Wnt signaling in bone", Endocrinology, 148, pp.2630~2634 (2007)
  12. Boyden LM, "High bone density due to a mutation in LDL-receptor-related protein 5", N Engl J Med, 346, pp.1513~1521 (2002)
  13. Day TF, "Wnt", beta-catenin signaling in mesenchymal progenitors controls osteoblast, chondrocyte differentiation during vertebrate skeletogenesis, 2005, pp.8, 739~750
  14. Kawano Y, "Secreted antagonists of the Wnt signalling pathway", J Cell Sci, 116, pp.2627~2634 (2003)
  15. Mukhopadhyay M, "Dickkopf1 is required for embryonic head induction, limb morphogenesis in the mouse", Dev Cell, 1, pp.423~434 (2001)
  16. Li J, "Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia", Bone, 39, pp.754~766 (2006)
  17. Morvan F, "Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation, bone mass", J Bone Miner Res, 21, pp.934~945 (2006)
  18. Hall CL, "Prostate cancer cells promote osteoblastic bone metastases through Wnts", Cancer Res, 65, pp.7554~7560 (2005)
  19. Tian E, "The role of the Wnt-signaling antagonist Dkk1 in the development of osteolytic lesions in multiple myeloma", N Engl J Med, 349, pp.2483~2494 (2003)
  20. Tang N, "BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt", beta-catenin signalling, 2009, pp.13, 2448~2464
  21. Kim HK, "High-concentration of BMP2 reduces cell proliferation, increases apoptosis via Dkk1, SOST in human primary periosteal cells", Bone, 54, pp.141~150 (2013)
  22. Zhang H, "Canonical Wnt signaling acts synergistically on BMP9-induced osteo", odontoblastic differentiation of stem cells of dental apical papilla(SCAPs), 2015, pp.39, 145~154
  23. Lou J, "Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1", 2, 2000, pp.268, 757~762
  24. Dao-jing Xu, "Smads, p38 and ERK1", 2 are involved in BMP9-induced osteogenic differentiation of C3H10T1, BMB Reports, pp.2012, 45(4)[DOI]
  25. Liao J, "Sox9 potentiates BMP2-induced chondrogenic differentiation, inhibits BMP2-induced osteogenic differentiation", PLoS One, 9, pp.e89025~ (2014)
  26. Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
  27. Petite H, "Tissue-engineered bone regeneration", Nat Biotechnol, 18, pp.959~963 (2000)
  28. Kang Q, "Characterization of the distinct orthotopic bone-forming activity of 14BMPs using recombinant adenovirus-mediated gene delivery", Gene Ther, 11, pp.1312~1320 (2004)
  29. Diarra D, "Dickkopf-1 is a master regulator of joint remodeling", Nat Med, 13, pp.156~163 (2007)
  30. Weng LH, "Inflammation induction of Dickkopf-1 mediates chondrocyte apoptosis in osteoarthritic joint", Osteoarthritis Cartilage, 17, pp.933~943 (2009)
  31. Kamiya N, "Wnt inhibitors Dkk1, Sost are downstream targets of BMP signaling through the type IA receptor(BMPRIA)in osteoblasts", J Bone Miner Res, 25, pp.200~210 (2010)
  32. Nakashima K, "The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation, bone formation", Cell, 108, pp.17~29 (2002)
  33. Zhang C, "Characterization of Dkk1 gene regulation by the osteoblast-specific transcription factor Osx", Biochem Biophys Res Commun, 420, pp.782~786 (2012)
  34. Zuzarte-Luis V, "A new role for BMP5 during limb development acting through the synergic activation of Smad, MAPK pathways", Dev Biol, 272, pp.39~52 (2004)
  35. Zhang R, "Wnt", beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts, 2013, pp.52, 145~156
  36. Butler JS, "Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation", BMC Musculoskelet Disord, 11, pp.210~ (2010)
  37. Luo J, "A protocol for rapid generation of recombinant adenoviruses using the AdEasy system", Nat Protoc, 2, pp.1236~1247 (2007)

관련 논문AI추천

Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cellsDao-jing Xu, Jin Wang, Jin-yong Luo, Juan-wen He, Ya-guang Weng, Ying-ze Zhao생화학분자생물학회 · BMB Reports2012 · 제45권 제4호Dikkopf-2, -3 and -4 Enhance Early Osteoblastic Differentiation in Mouse Mesenchymal Progenitor Cells and Stimulate Apoptosis in Osteoblastic Cells김상완, 김성연, 선현진, 신찬수, 양재연, 정주연, 조선욱대한골대사학회 · 대한골대사학회지2011 · 제18권 제2호Biphasic effects of TGFβ1 on BMP9-induced osteogenic differentiation of mesenchymal stem cellsBo Liu, Jinyong Luo, Liang Chen, Liangjun Yin, Ning Hu, Rui-Dong Li, Tong-Chuan He, Wei Huang, Wei Shui, Xiaoji Luo, Xi Liang, Zhong-Liang Deng생화학분자생물학회 · BMB Reports2012 · 제45권 제9호IGF1 potentiates BMP9-induced osteogenic differentiation in mesenchymal stem cells through the enhancement of BMP/Smad signalingChang-Jun Pi, Liang Chen, Liangjun Yin, Nian Wu, Ran-Xi Zhang, Xiang Zou, Zhong-Liang Deng생화학분자생물학회 · BMB Reports2016 · 제49권 제2호Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cellsDan Zhao, Jing Xu, Jin Wang, Jin-yong Luo, Juan-wen He, Li Li, Min Tang, Qian Dong, Tao Song, Wen-juan Wang, Xing-lian Duan, Xue Yang, Yan-fang Zhao, Yan Xiao, Yi-wen Liang생화학분자생물학회 · BMB Reports2013 · 제46권 제8호Transforming Growth Factor-β Signaling Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells via Activation of Wnt/β-Catenin PathwayAzita Parvaneh Tafreshi대한골대사학회 · 대한골대사학회지2025 · 제32권 제1호

이 간행물의 다른 논문 (9건)